D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 104 Citations 50,233 359 World Ranking 230 National Ranking 17
Medicine D-index 113 Citations 61,381 485 World Ranking 2141 National Ranking 210

Research.com Recognitions

Awards & Achievements

Fellow of The Academy of Medical Sciences, United Kingdom

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Asthma
  • Gene

Christopher E. Brightling mostly deals with Asthma, Immunology, Internal medicine, Sputum and COPD. His Asthma research incorporates elements of Eosinophilia, Respiratory disease and Exacerbation. He combines subjects such as Bronchoalveolar lavage, Lung, Eosinophilic and Airway with his study of Immunology.

His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology, Placebo and Surgery. His work on Sputum Cytology as part of general Sputum research is frequently linked to Absolute neutrophil count, thereby connecting diverse disciplines of science. His COPD study integrates concerns from other disciplines, such as Framingham Risk Score, Oncology, Cause of death, Chronic bronchitis and Prospective cohort study.

His most cited work include:

  • Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report. (2287 citations)
  • International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma (1799 citations)
  • Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. (1443 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Asthma, Immunology, Internal medicine, COPD and Sputum. His Asthma research is multidisciplinary, relying on both Eosinophilia, Pathology, Intensive care medicine and Airway. His work deals with themes such as Disease and Eosinophilic, which intersect with Immunology.

His Internal medicine study combines topics in areas such as Gastroenterology, Placebo, Endocrinology and Cardiology. Christopher E. Brightling combines subjects such as Microbiome, Pulmonary disease, Exacerbation, Lung and Biomarker with his study of COPD. His Sputum research is multidisciplinary, incorporating perspectives in Exhaled nitric oxide, Respiratory disease, Haemophilus influenzae and Microbiology.

He most often published in these fields:

  • Asthma (45.66%)
  • Immunology (42.64%)
  • Internal medicine (33.71%)

What were the highlights of his more recent work (between 2017-2021)?

  • Asthma (45.66%)
  • Internal medicine (33.71%)
  • COPD (26.67%)

In recent papers he was focusing on the following fields of study:

Asthma, Internal medicine, COPD, Immunology and Sputum are his primary areas of study. Christopher E. Brightling has included themes like Randomized controlled trial, Airway, Disease and Intensive care medicine in his Asthma study. His work deals with themes such as Gastroenterology and Placebo, which intersect with Internal medicine.

His work in COPD addresses issues such as Exacerbation, which are connected to fields such as Observational study and Biomarker. His Immunology study combines topics in areas such as Phenotype and Dysbiosis. His study on Sputum also encompasses disciplines like

  • Eosinophilic which intersects with area such as Inflammation,
  • Spirometry together with FEV1/FVC ratio.

Between 2017 and 2021, his most popular works were:

  • Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report. (2287 citations)
  • Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report (366 citations)
  • Multiancestry association study identifies new asthma risk loci that colocalize with immune-cell enhancer marks (203 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Asthma

His primary areas of study are Asthma, Internal medicine, COPD, Immunology and Sputum. His research in Asthma intersects with topics in Eosinophilia, Genome-wide association study and Intensive care medicine. Many of his research projects under Internal medicine are closely connected to In patient with In patient, tying the diverse disciplines of science together.

His work carried out in the field of COPD brings together such families of science as Benralizumab, Vital capacity, Pulmonary disease, Exacerbation and Dysbiosis. Christopher E. Brightling has researched Immunology in several fields, including Streptococcus pneumoniae, Phenotype, Receptor, Prostaglandin D2 and Airway. As a member of one scientific family, Christopher E. Brightling mostly works in the field of Sputum, focusing on Microbiome and, on occasion, Computational biology and Metagenomics.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

J. Bousquet;H. J. Schünemann;B. Samolinski;P. Demoly.
The Journal of Allergy and Clinical Immunology (2012)

7730 Citations

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

Kian Fan Chung;Sally E. Wenzel;Jan L. Brozek;Andrew Bush.
European Respiratory Journal (2014)

2805 Citations

Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report.

P Horby;W S Lim;Emberson.
The New England Journal of Medicine (2020)

2287 Citations

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.

Ruth H Green;Christopher E Brightling;Susan McKenna;Beverley Hargadon.
The Lancet (2002)

1979 Citations

Cluster analysis and clinical asthma phenotypes.

Pranab Haldar;Ian D. Pavord;Dominic E. Shaw;Michael A. Berry.
American Journal of Respiratory and Critical Care Medicine (2008)

1944 Citations

Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma

Pranabashis Haldar;Christopher E. Brightling;Beverley Hargadon;Sumit Gupta.
The New England Journal of Medicine (2009)

1835 Citations

Mast-Cell Infiltration of Airway Smooth Muscle in Asthma

Christopher E. Brightling;Peter Bradding;Fiona A. Symon;Stephen T. Holgate.
The New England Journal of Medicine (2002)

1406 Citations

Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids

R H Green;C E Brightling;G Woltmann;D Parker.
Thorax (2002)

968 Citations

Evidence of a role of tumor necrosis factor alpha in refractory asthma.

Mike A. Berry;Beverley Hargadon;Maria Shelley;Debbie Parker.
The New England Journal of Medicine (2006)

959 Citations

Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Identification of Biologic Clusters and Their Biomarkers

Mona Bafadhel;Susan McKenna;Sarah Terry;Vijay Mistry.
American Journal of Respiratory and Critical Care Medicine (2011)

905 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Christopher E. Brightling

Peter G. Gibson

Peter G. Gibson

University of Newcastle Australia

Publications: 290

Ian D. Pavord

Ian D. Pavord

University of Oxford

Publications: 197

Jean Bousquet

Jean Bousquet

Inserm : Institut national de la santé et de la recherche médicale

Publications: 183

Kian Fan Chung

Kian Fan Chung

National Institutes of Health

Publications: 178

Sally E. Wenzel

Sally E. Wenzel

University of Pittsburgh

Publications: 150

Peter J. Barnes

Peter J. Barnes

Imperial College London

Publications: 132

Guy Brusselle

Guy Brusselle

Ghent University Hospital

Publications: 124

Ian M. Adcock

Ian M. Adcock

National Institutes of Health

Publications: 117

Giorgio Walter Canonica

Giorgio Walter Canonica

Humanitas University

Publications: 115

Claus Bachert

Claus Bachert

Ghent University

Publications: 115

Andrew Bush

Andrew Bush

National Institutes of Health

Publications: 107

Dave Singh

Dave Singh

University of Manchester

Publications: 104

Jodie L. Simpson

Jodie L. Simpson

University of Newcastle Australia

Publications: 104

Anne B. Chang

Anne B. Chang

Boston Children's Hospital

Publications: 99

Peter Hellings

Peter Hellings

KU Leuven

Publications: 99

Parameswaran Nair

Parameswaran Nair

McMaster University

Publications: 99

Something went wrong. Please try again later.